Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Stock Report

| More

U.S. FDA Accepts Biologies License Application for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review

Posted On: 2017-02-16 19:55:29

Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan's Biologics License Application (BLA) for MYL-1401H, a proposed biosimilar to Neulasta® (pegfilgrastim), for filing through the 351(k) pathway.

The proposed biosimilar to Neulasta is used to reduce the duration of neutropenia (low count of neutrophils, a type of white blood cells) and the incidence of fever associated with neutropenia in adult patients treated with chemotherapy in certain types of cancer.

The FDA goal date set under the Biosimilar User Fee Act (BsUFA) is Oct. 9, 2017.

Mylan President Rajiv Malik commented: "We're proud of the FDA acceptance of our BLA for proposed biosimilar pegfilgrastim. This is the second BLA accepted for review by FDA as part of the Mylan and Biocon partnership within the past two months. The milestone builds upon the acceptance of regulatory filings for proposed biosimilar pegfilgrastim in Europe, Australia, and Canada and reinforces our dedication and commitment to establishing a global platform for this product. Once approved, proposed biosimilar pegfilgrastim will complement Mylan's broad oncology portfolio focused on expanding access to more affordable treatments for multiple types of cancer."

Dr. Arun Chandavarkar, CEO and Joint Managing Director, Biocon, said: "We are extremely pleased with the regulatory progress of our biosimilars in the U.S. The FDA's acceptance for review of our second BLA for a proposed biosimilar developed by Biocon and Mylan is an outcome of our strong R&D and manufacturing capabilities. Once approved, our proposed biosimilar pegfilgrastim will provide a high quality alternative to branded pegfilgrastim (Neulasta®) for cancer patients during cytotoxic chemotherapy. It will expand our oncology portfolio and further enable us to fulfil our promise of making cancer-care affordable and accessible for patients across the globe."

Shares of BIOCON LTD. was last trading in BSE at Rs.1094.75 as compared to the previous close of Rs. 1057. The total number of shares traded during the day was 39494 in over 2259 trades.

The stock hit an intraday high of Rs. 1098.85 and intraday low of 1053. The net turnover during the day was Rs. 42475635.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Ipca Laboratories Limited appoints CreateID8 for Brand Strategy and Design
Indiabulls Real Estate Ltd acquires 10.08% stake in Indiabulls Infraestate Limited
Pecos Hotels and Pubs Ltd receives notice from Excise Department
Non-Executive Independent Director quits OK Play India Ltd
Sam Industries Ltd accepts resignation of independent director
Sangam Advisors Ltd receives 'Letter of Award' by Maharashtra State Power Generation Corporation
3i Infotech Ltd calls for Board Meeting on July 22, 2017
Avonmore Capital & Management Services Limited receives approval for stake sale
Rajputana Investment and Finance Ltd Board recommends Bonus Issue
Everest Industries Ltd to announce Q1 results on July 26, 2017
Marico Ltd appoints additional independent director
TCS BaNCS to Power Canada's premier exchange TMX Group with a new consolidated technology Platform
Monnet Project Developers Ltd announces resignation of company secretary
Richa Industries Ltd calls for Board Meeting on June 30, 2017
Sudarshan Chemical Industries Ltd to approve Q1 results on Aug 10, 2017
HGS recognized as Best Champion Employer under DDU-GKY by Ministry of Rural Development, Government of India
GIC Housing Finance Ltd to consider Q1 results on July 24, 2017
Sona Koyo Steering Systems Ltd announces sad demise of independent director
Tata Sponge Iron Limited calls for Board Meeting on July 21, 2017
HCL's 'VelocITy' Attains 'VMware Validated Design 4.0' Certification from VMware
K P Energy orders Windcube
Brickworks Rating upgrades rating of Sanwaria Agro Oils Ltd
Taparia Tools Limited appoints independent director
Nectar Lifesciences Ltd Board recommends Final Dividend of Rs. 0.05 for 2016-17
Stampede Capital Ltd updates on associate company
Confidence Petroleum India Limited arm commissions new unit near Nagpur
BHEL bags EPC order for 15 MW Solar Photovoltaic Power Plant
Gujarat Terce Laboratories Ltd appoints independent director
Indian Papayas shipped by Sea packed in Uflex's Flexfresh create ripples in Dubai Market
PSP Projects Ltd receives award from Realty Plus Excellence Awards Gujarat 2017
PTron unveils "Spark" Bluetooth sporty magnetic headset! Exclusively on LatestOne.com
Larsen & Toubro Infotech Ltd Powers its Mosaic Decisions Platform with Microsoft Azure and Microsoft Cortana Intelligence Suite
Winsome Textile Industries Ltd announces resignation of company secretary
Mindteck India Limited receives LOA from Bhopal Municipal Corporation
Reliance Infrastructure Ltd clarifies on spinning off transport business
Zydus receives final approval from the USFDA for Entecavir Tablets
L&T Construction Wins Orders Valued Rs.2552 Crores
SAIL clarifies on disinvestment news
Natco receives final approval for generic Azacitidine for injection Vidaza® for US market
Wintac Ltd promoter changes name as Veego Pharma, LLC
Glenmark Pharmaceuticals receives ANDA Approval for Indomethacin Extended-Release Capsules USP, 75 mg
Sun Pharma & NIV sign agreement to fight Zika, Chikungunya and Dengue
Valecha Engineering Limited bags project worth Rs. 294.40 Crores
Bajaj Healthcare Ltd announces resignation of Company Secretary
Infibeam Incorporation Ltd Board to consider Stock Split of Equity Share
Hinduja Ventures Ltd allotted shares of Hinduja Leyland Finance Ltd
Kkalpana Industries India Ltd approves appointment of additional director
Valecha Engineering Ltd appoints Whole Time Director
Competent Automobiles Company Ltd appoints new CFO
Morganite Crucible India Ltd to acquire further 49% in Diamond Crucible Company Ltd


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017